"Methadone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
| Descriptor ID |
D008691
|
| MeSH Number(s) |
D02.522.675
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methadone".
Below are MeSH descriptors whose meaning is more specific than "Methadone".
This graph shows the total number of publications written about "Methadone" by people in this website by year, and whether "Methadone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 5 | 0 | 5 |
| 2014 | 1 | 2 | 3 |
| 2015 | 6 | 0 | 6 |
| 2016 | 4 | 3 | 7 |
| 2017 | 4 | 3 | 7 |
| 2018 | 3 | 6 | 9 |
| 2019 | 2 | 4 | 6 |
| 2020 | 2 | 4 | 6 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 5 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methadone" by people in Profiles.
-
Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 Aug 29; 19(1):60.
-
Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019. Drug Alcohol Depend. 2024 Sep 01; 262:111392.
-
Englander H, Chappuy M, Krawczyck N, Bratberg J, Potee R, Jauffret-Roustide M, Rolland B. Comparing methadone policy and practice in France and the US: Implications for US policy reform. Int J Drug Policy. 2024 Jul; 129:104487.
-
Feeney ME, Law AC, Walkey AJ, Bosch NA. Variation in Use of Medications for Opioid Use Disorder in Critically Ill Patients Across the United States. Crit Care Med. 2024 Jul 01; 52(7):e365-e375.
-
Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Netw Open. 2024 Mar 04; 7(3):e242732.
-
Michener PS, Evans EA, Ferguson WJ, Friedmann PD. Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives. Addict Sci Clin Pract. 2024 02 12; 19(1):10.
-
Kelly LM, Alessi SM, Rash CJ, Zajac K. Predictors of Suicidal Ideation and Continued Substance Use Problems Among Patients Receiving Methadone Maintenance Treatment Who Have Co-Occurring Cocaine Use Disorder. Subst Use Misuse. 2024; 59(5):752-762.
-
Michener PS, Knee A, Wilson D, Boama-Nyarko E, Friedmann PD. Association of random and observed urine drug screening with long-term retention in opioid treatment programs. Drug Alcohol Depend. 2024 Feb 01; 255:111067.
-
Tsui JI, Whitney BM, Korthuis PT, Chan B, Pho MT, Jenkins WD, Young AM, Cooper HLF, Friedmann PD, Stopka TJ, de Gijsel D, Miller WC, Go VF, Westergaard R, Brown R, Seal DW, Zule WA, Feinberg J, Smith GS, Mixson LS, Fredericksen R, Crane HM, Delaney JA. Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs. Drug Alcohol Depend. 2023 09 01; 250:110911.
-
Braun HM, Potee RA. Individualizing methadone treatment with split dosing: An underutilized tool. J Subst Use Addict Treat. 2023 09; 152:209096.